261 related articles for article (PubMed ID: 16997520)
1. Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer.
Lin H; Gebhardt M; Bian S; Kwon KA; Shim CK; Chung SJ; Kim DD
Int J Pharm; 2007 Feb; 330(1-2):23-31. PubMed ID: 16997520
[TBL] [Abstract][Full Text] [Related]
2. Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer.
Lin H; Yoo JW; Roh HJ; Lee MK; Chung SJ; Shim CK; Kim DD
Eur J Pharm Sci; 2005 Oct; 26(2):203-10. PubMed ID: 16087322
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
Huh Y; Cho HJ; Yoon IS; Choi MK; Kim JS; Oh E; Chung SJ; Shim CK; Kim DD
Eur J Pharm Sci; 2010 Apr; 40(1):9-15. PubMed ID: 20149868
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
[TBL] [Abstract][Full Text] [Related]
5. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
Abdelaziz MM; Devalia JL; Khair OA; Bayram H; Prior AJ; Davies RJ
J Allergy Clin Immunol; 1998 Mar; 101(3):410-20. PubMed ID: 9525460
[TBL] [Abstract][Full Text] [Related]
6. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
[TBL] [Abstract][Full Text] [Related]
7. Assessment of fexofenadine hydrochloride permeability and dissolution with an anionic surfactant using Caco-2 cells.
Gundogdu E; Gonzalez Alvarez I; Bermejo Sanz M; Karasulu E
Pharmazie; 2011 Oct; 66(10):747-53. PubMed ID: 22026155
[TBL] [Abstract][Full Text] [Related]
8. [Study of the effect of surface-active agents on living cells, used as component parts in microemulsions, based on their chemical structures and critical micelle-formative concentration (CMC)].
Ujhelyi Z; Vecsernyés M; Bácskay I
Acta Pharm Hung; 2013; 83(1):3-11. PubMed ID: 23821837
[TBL] [Abstract][Full Text] [Related]
9. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
10. An improved primary human nasal cell culture for the simultaneous determination of transepithelial transport and ciliary beat frequency.
Mallants R; Vlaeminck V; Jorissen M; Augustijns P
J Pharm Pharmacol; 2009 Jul; 61(7):883-90. PubMed ID: 19589230
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
Ujie K; Oda M; Kobayashi M; Saitoh H
Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
[TBL] [Abstract][Full Text] [Related]
12. Effects of anionic surfactants on hamster small intestinal membrane structure and function: relationship to surface activity.
Gullikson GW; Cline WS; Lorenzsonn V; Benz L; Olsen WA; Bass P
Gastroenterology; 1977 Sep; 73(3):501-11. PubMed ID: 892348
[TBL] [Abstract][Full Text] [Related]
13. Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro.
Tirumalasetty PP; Eley JG
J Pharm Pharm Sci; 2006; 9(1):32-9. PubMed ID: 16849006
[TBL] [Abstract][Full Text] [Related]
14. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
Dimitrijevic D; Shaw AJ; Florence AT
J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
[TBL] [Abstract][Full Text] [Related]
15. Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells.
Amoako-Tuffour M; Yeung PK; Agu RU
Acta Pharm; 2009 Dec; 59(4):395-405. PubMed ID: 19919929
[TBL] [Abstract][Full Text] [Related]
16. Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers.
Fischer SM; Brandl M; Fricker G
Eur J Pharm Biopharm; 2011 Oct; 79(2):416-22. PubMed ID: 21549839
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
Miura M; Uno T; Tateishi T; Suzuki T
Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
[TBL] [Abstract][Full Text] [Related]
18. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
19. Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing.
Muendoerfer M; Schaefer UF; Koenig P; Walk JS; Loos P; Balbach S; Eichinger T; Lehr CM
Int J Pharm; 2010 Jun; 392(1-2):134-40. PubMed ID: 20347022
[TBL] [Abstract][Full Text] [Related]
20. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.
Sha X; Yan G; Wu Y; Li J; Fang X
Eur J Pharm Sci; 2005 Apr; 24(5):477-86. PubMed ID: 15784337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
